Search

This report contains information on NHMRC administration and performance, and a record of our activities for the reporting period 2020–21. An accessible version of this document is available on the Transparency Portal.

This report contains information on NHMRC administration and performance, and a record of our activities for the reporting period 2019–20. An accessible version of this document is available on the Transparency Portal.

This report contains information on NHMRC administration and performance, and a record of our activities for the reporting period 2021–22. An accessible version of this document is available on the Transparency Portal.

This report contains information on NHMRC administration and performance, and a record of our activities for the reporting period 2022–23. An accessible version of this document is available on the Transparency Portal.

It is an inspiring time for health and medical research in Australia as the National Health and Medical Research Council (NHMRC) sets the standard for achieving gender equity through its largest grant scheme, Investigator Grants.

Picato® is a prescription gel that treats skin actinic keratosis (potentially pre-cancerous sunspots). The journey to develop this product began in the 1970s when Queensland researcher, Jim Aylward, became interested in a local farming story about the healing properties of the sap of the radium weed Euphorbia peplus (E. peplus) when applied to sunspots on the skin.

MRFF – Preventive and Public Health Research Initiative – 2023 Optimising Screening, Diagnosis and Management of Obstructive Sleep Apnoea Grant Opportunity

NHMRC opened a Targeted Call for Research (TCR) into Frailty in Hospital Care: Complex Health Care on 31 October 2018 and closed on 30 January 2019. Due to an administrative issue at the close of minimum data which disadvantaged some applications, NHMRC elected to reopen this call in the interests of equity and fairness. The re-opened call closed on 21 March 2019.

NHMRC opened a Targeted Call for Research (TCR) into Per- and Poly-Fluoroalkylated Substances (PFAS) on 19 December 2018. Applications closed on 1 May 2019.

NHMRC opened a Targeted Call for Research (TCR) into Biotoxin-related illnesses on 21 July 2021. Applications closed on 15 September 2021.

In 2022, working with its Health Research Impact Committee, National Health and Medical Research Council (NHMRC) developed the NHMRC Research Impact Position Statement.

NHMRC opened a Targeted Call for Research (TCR) into Healthy Ageing of Aboriginal and Torres Strait Islander Peoples on 20 June 2018. Applications closed on 12 September 2018.